Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-037738)

Filing Details

Accession Number:: 0001209191-17-037738
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-05 16:33:12
Reporting Period:: 2017-06-01

Filing Date:: 2017-06-05
Accepted Time:: 2017-06-05 16:33:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1598646	Minerva Neurosciences Inc.	NERV	Pharmaceutical Preparations (2834)	260784194

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1617236	S. Mark Levine	C/O Minerva Neurosciences, Inc. 1601 Trapelo Road, Suite 284 Waltham MA 02451	Svp,General Counsel & Sec.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-06-01	17,500	$5.19	17,500	No	4	M	Direct
Common Stock	Disposition	2017-06-01	17,500	$11.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2017-06-01	17,500	$0.00	17,500	$5.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
39,774		2025-04-13	No	4	M	Direct

Footnotes

These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016.
This option vested as to 25% for the shares on April 14, 2016 and then in quarterly installments over 3 years thereafter.